Country Profile

Zimbabwe

Zimbabwe is a growing market for Indian pharmaceuticals — $93.4M in FY 2025–26. Medicines accounts for 89% of shipments, with vaccines contributing $6.89M.

🇿🇼 $93.4M · 0.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$93.4M
Exports FY2025–26 DGCIS
0.9×
Growth FY2015→2026
89%
Medicines Share
5
Product Categories Supplied
12
Years of Trade Data
Zimbabwe is a growing market for Indian pharmaceuticals — $93.4M in FY 2025–26. Medicines accounts for 89% of shipments, with vaccines contributing $6.89M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $83.2M (89.1%) Vaccines $6.89M (7.4%) Medicine Ingredients $2.11M (2.3%) Surgical & Hospital Supplies $1.07M (1.1%) Traditional & Herbal $163K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Zimbabwe in the RBI overseas direct investment dataset (2011–2026).